Project Grant HT94252411103

Award Date 9/30/24
Completion Date 9/29/28
Dollars Obligated $473K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Nigeria
Similar Awards
The Department of the Army Medical Command awarded a $1,065,567 project grant to Baylor College of Medicine to develop a novel therapeutic strategy for prostate cancer in African American men. The grant was awarded under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative and impactful medical solutions. Funding will support Baylor College of Medicine's...
The U.S. Department of the Army Medical Command awarded a $4,623,272 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Mayo Clinic Jacksonville (A Nonprofit Corporation), doing business as Scott Lynch MD. The grant, titled "The Inclusive Cancer Care Research Equity (ICCARE) for Black Men Consortium," will support advanced biomedical research focused on transforming healthcare for military service members and the broader public. The four-year...
The Defense Health Agency awarded a $468,672 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Georgia College & State University. The grant, titled "The Inclusive Cancer Care Research Equity (ICCARE) for Black Men Consortium," will fund research focused on examining health-seeking behaviors, decision-making, psychosocial effects, and coping mechanisms among Black men with prostate cancer. The project will also test the efficacy of...
This $584,828 federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the "HEROIC PROSTATE CANCER PRECISION HEALTH (PCAPH) AFRICA1K: POWERING PRECISION HEALTH TO IMPROVE PROSTATE CANCER OUTCOMES IN AFRICA" initiative. The grant, awarded to the University of Nairobi, a prominent Kenyan research university, aims to conduct advanced biomedical research and capacity-building focused on improving...
This federal Project Grant award of $1,839,317.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Illinois. The grant aims to evaluate the interrelated roles of environmental exposures and multi-omic factors on high-risk prostate cancer among men of African ancestry. Key components include: Establishing a translational study site at the University of Calabar Teaching Hospital in Nigeria to recruit 120...
The Department of the Army Medical Command awarded a $699,534 project grant to the Institute of Cancer Research: Royal Cancer Hospital under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will support research on B7-H3 (CD276) as a therapeutic target in lethal prostate cancers. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research that investigates medical solutions...
The Department of the Army Medical Command awarded Duke University a $482,890 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from April 1, 2022 to March 31, 2024 to target the oncogenomic function of the E2F8 transcription factor in lethal prostate cancer. Through this funding, Duke University researchers will investigate medical solutions for prostate cancer at the genomic level, with the aim of transforming healthcare for...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $738,775.00 to the University of Pretoria in South Africa to support the "HEROIC PROSTATE CANCER PRECISION HEALTH (PCAPH) AFRICA1K: POWERING PRECISION HEALTH TO IMPROVE PROSTATE CANCER OUTCOMES IN AFRICA" research project. The award period runs from Sep 30, 2024 to Mar 13, 2025. This funding supports advanced biomedical research aimed at...
The Defense Health Agency awarded a $1,346,633 Project Grant to the George Washington University under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research titled "A PRIMARY ROLE FOR THE CIRCULATORY MICROENVIRONMENT IN AFRICAN AMERICAN PROSTATE CANCER DISPARITIES?" from May 15, 2023 to May 14, 2026. As the prime awardee, George Washington University will investigate medical solutions for prostate cancer disparities affecting African...
The Department of the Army Medical Command awarded a $520,751 Project Grant to the Veteran Research And Education Foundation Of ST Louis through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2022 to July 31, 2026 to improve outcomes for prostate cancer patients based on comorbidities, with the goal of developing personalized medicine approaches. Through this award, the Foundation will conduct research to investigate medical...

The Department of the Army Medical Command, through the Military Medical Research and Development federal grant program (CFDA 12.420), awarded a $473,463 project grant to Covenant University in Nigeria. The grant, titled the "Inclusive Cancer Care Research Equity (ICCARE) for Black Men Consortium," will fund research to investigate cancer care and outcomes for Black men. This grant aligns with the program's focus on advanced biomedical research initiatives that aim to transform healthcare for military service members and the broader public. As a prominent research university, Covenant University has established itself as a significant recipient of federal grants, collaborating with U.S. institutions on studies related to health disparities, genomics, and cancer research.

Generated 7/1/25, 4:58 AM